PRMT3 and central nervous system cancer: In this study, we explored the expression levels and prognostic values of PRMT genes in gliomas using Gene Expression Profiling Interactive Analysis (GEPIA) [27] and found that PRMT3 is the most significantly enriched member of the PRMT family in high- and low-grade gliomas.